Bringing young people's voices to the drug policy table with Ruby Rose Lawlor
We are joined by YouthRise's Executive Director, Ruby Rose Lawlor, to discuss influencing drug policy change at the UN, full spectrum harm reduction and the recent recommendation to decriminalise drug...
14 Syys 52min
Developing digital infrastructure within harm reduction with Mark Tudor
In this episode, we are joined by Mark Tudor, co-founder of Substancy. Mark has worked in the harm reduction field for over 30 years, but most recently has established Substancy, a social enterprise t...
1 Heinä 30min
What is trauma-informed practice?
We are joined by Sarah, CAVDAS Alliance Manager, to shed light on what trauma-informed practice is and why it matters. Sarah has led Barod's journey towards becoming a trauma-informed organisation and...
17 Kesä 37min
Image and Performance Enhancing Drugs: What's the appeal?
In this episode, we are joined by Liberty Musungo, Image and Performance Enhancing Drugs (IPEDs) Lead for Dyfed Drug and Alcohol Service (DDAS). Liberty takes us through what IPEDs are and how they wo...
2 Kesä 45min
How do we become anti-stigma?
In this Learning at Work Week special, we are joined by Barod's Operations Manager, Sian, to discuss how we can move from being non-stigmatising, to actively challenging and becoming anti-stigma.In th...
19 Touko 23min
Inside the Green Party’s Plan to Legalise Drugs
In this episode, we are joined by Dr. Carrie Hamilton and Michael Wakelyn-Green, from the Green Party Drug Policy Working Group, to explore the party's proposed approach to drug policy. With recent fo...
21 Huhti 43min
Drugs on the brain with Professor David Nutt
In this episode, we’re joined by leading neuropsychopharmacologist, Professor David Nutt, for a deep dive into the human brain and its relationship with drugs. We discuss whether our brains are built ...
25 Maalis 54min
